In our previous study, we reported that RASAL2 was downregulated in bladder and kidney cancers, which regulated angiogenesis [13, 14], while RASAL2 also affected stemness and epithelial-mesenchymal transition in bladder cancer [15]. Here, RASAL2 is linked to kidney cancer.